Pancreatic Acinar Cell Carcinoma in the Setting of a BRCA1 Germline Mutation
Pancreatic acinar cell carcinoma (PACC) is a rare neoplasm of the exocrine pancreas. PACC’s molecular and genetic features are poorly elucidated compared with pancreatic ductal cell carcinoma. Here, we present the patient case of a woman in her late 60s, with a BRCA1 germline mutation and a medical...
Saved in:
| Main Authors: | Leticia Campoverde, Monika Vyas, Andrea Bullock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2022-09-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Squamous Cell Carcinoma of the Pancreas in a Patient with Germline BRCA2 Mutation-Response to Neoadjuvant Radiochemotherapy
by: Anne M. Schultheis, et al.
Published: (2014-01-01) -
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
by: Tarun Mehra, et al.
Published: (2024-01-01) -
Germline Mutations in BRCA1 and BRCA2 in Breast Cancer Patients with High Genetic Risk in Turkish Population
by: Caglayan Geredeli, et al.
Published: (2019-01-01) -
Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01) -
Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
by: Tarun Mehra, et al.
Published: (2024-01-01)